Publication | Closed Access

Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice

Spinal Cord InjuryMedicineDiabetesPharmacologyDiabetic MiceDiabetic NeuropathyNeuropharmacologyNeuroimmunologySpinal AdministrationNeuropeptides